PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for May 20, 2004 Subscribe to this News Feed    
 

Mercury in baby vaccines may have brain damaged thousands of U.S. children

Thimerosal, an ingredient found in numerous baby vaccines may have contributed to the explosion of "Autism" in the U.S. in recent years. Thimerosal is 49.6% Mercury, a known neuro-toxin. The Bush administration has attempted to protect the pharmaceutical industry which was responsible for this national tragedy.

(PRWEB) May 20, 2004 -- Thousands of American children were exposed to as much as 40 times the mercury safety limit that was established by the E.P.A. from the routine baby vaccines that were required by the federal government for all children entering the public school system.

The Bush Administration has tried to cover up these facts and has tried to illegally protect the drug industry from law suits filed by victimized families seeking relief.

The Bush Administration has close ties with the drug industry. There are other highly suspicious circumstances that surround this American tragedy.

It has been determined that Mercury poisoning and "autism" are identical in symtoms.

This national tragedy may have resulted in over 118,000 cases of Mercury induced "autism" in American children.

Every parent or soon to be parent needs the truth to be told and the U.S. Government needs to come clean with the facts that are surrounding this whole issue.

The book that tells the story is titled
Mercury: The winged messenger. Published
by Authorhouse.com

Book Link: www.authorhouse.com/bookstore/itemdetail.aspx?bookid=20953

OPTIONS
Printer Friendly Version
Email this story to a colleague
CONTACT INFORMATION
Courtney Zietzke
BOOK PROMO
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.